Literature DB >> 3806134

Minicore myopathy with dominant inheritance.

L Paljärvi, H Kalimo, H Lang, M L Savontaus, V Sonninen.   

Abstract

Minicore disease (multicore disease) is a benign myopathy characterized by segmental muscle fibre degeneration with disruption of myofibrils and loss of mitochondria. The disease is generally thought to occur either sporadically or follow an autosomal recessive mode of inheritance. We describe 2 patients, a mother and her son, with essentially non-progressive weakness of both proximal and distal muscles. Biopsies from both patients showed focal defects of oxidative enzyme activity as well as focal disturbances of cross-striation typical of minicore myopathy. Normal fibre type differentiation was lacking. Three other families reported in the literature suggest dominant inheritance of minicore myopathy or closely related disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806134     DOI: 10.1016/0022-510x(87)90202-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Multicore myopathy associated with multiple pterygium syndrome and hypertrophic cardiomyopathy.

Authors:  M Ohkubo; T Ino; S Shimazaki; K Yabuto; R Okada; T Sato
Journal:  Pediatr Cardiol       Date:  1996 Jan-Feb       Impact factor: 1.655

2.  The rigid spine syndrome in two sisters.

Authors:  J A Vanneste; P B Augustijn; F C Stam
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

3.  Multicore myopathy in a patient with anhidrotic ectodermal dysplasia.

Authors:  C P Gordon; S Litz
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

4.  Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1.

Authors:  Yi Dai; Shengran Liang; Yan Huang; Lin Chen; Santasree Banerjee
Journal:  Oncotarget       Date:  2016-12-20

Review 5.  Multi-minicore Disease.

Authors:  Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2007-07-13       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.